Towarzystwo Funduszy Inwestycyjnych Pzu Sa Vertex Pharmaceuticals Inc Transaction History
Towarzystwo Funduszy Inwestycyjnych Pzu Sa
- $422 Billion
- Q3 2025
A detailed history of Towarzystwo Funduszy Inwestycyjnych Pzu Sa transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Towarzystwo Funduszy Inwestycyjnych Pzu Sa holds 1,189 shares of VRTX stock, worth $516,049. This represents 0.11% of its overall portfolio holdings.
Number of Shares
1,189
Previous 1,994
40.37%
Holding current value
$516,049
Previous $888 Million
47.54%
% of portfolio
0.11%
Previous 0.25%
Shares
11 transactions
Others Institutions Holding VRTX
# of Institutions
1,789Shares Held
231MCall Options Held
1.83MPut Options Held
1.21M-
Capital World Investors Los Angeles, CA25.9MShares$11.2 Billion1.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.2MShares$10.5 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.25 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.6MShares$7.18 Billion1.27% of portfolio
-
State Street Corp Boston, MA11.6MShares$5.04 Billion0.16% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $111B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...